Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -21.69 % |
3 Month Return | + 31.99 % |
1 Year Return | + 89.2 % |
Market Stats | |
Previous Close | ₹768.70 |
Open | ₹771.05 |
Volume | 7,876.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹635.23Cr |
P/E Ratio | 25.15 |
PEG Ratio | 4.85 |
Market Cap | ₹635.23 Cr |
P/B Ratio | 3.4 |
EPS | 28.64 |
Dividend Yield | 0.38 |
Sector | Pharmaceuticals |
ROE | 20.18 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹635.23 Cr | 382.46% | 0.54 | ₹23 Cr | ₹164 Cr | |
NA | ₹143.16 Cr | 73.55% | 0.56 | NA | NA | |
NA | ₹1,388.42 Cr | 84.92% | 0.51 | ₹25 Cr | ₹212 Cr | |
NA | ₹35.53 Cr | 14.76% | 0.54 | NA | NA | |
NA | ₹111.21 Cr | 51.29% | 0.55 | NA | NA |
Organisation | Titan Biotech Ltd |
Headquarters | New Delhi |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
In the last 3 years, Titan Biotech has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Best in 1 Year
In the last 1 year, Titan Biotech has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Profit Spike
Netprofit is up for the last 3 quarters, 5.0 Cr → 6.7 Cr (in ₹), with an average increase of 13.2% per quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 55.88% of holdings in Sep 2024 quarter
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 44.12% of holdings in Sep 2024 quarter
Price Dip
In the last 7 days, Titan Biotech stock has moved down by -4.5%
Revenue Fall
Revenue is down for the last 2 quarters, 43.74 Cr → 40.21 Cr (in ₹), with an average decrease of 8.1% per quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 55.88% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 44.12% | 0.00 | |
Others | 0% | 0.00 |
Titan Biotech Ltd in the last 5 years
Lowest (3.20x)
June 30, 2020
Today (25.15x)
November 19, 2024
Industry (54.42x)
November 19, 2024
Highest (32.11x)
October 21, 2024
Titan Biotech Ltd’s net profit jumped 2.76% since last year same period to ₹6.70Cr in the Q2 2024-2025. On a quarterly growth basis, Titan Biotech Ltd has generated 4.69% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Titan Biotech Ltd has declared dividend of ₹2 - translating a dividend yield of 0.50%.
Read More about DividendsBearish
Neutral
Bullish
Titan Biotech Ltd is currently in a Bearish trading position according to technical analysis indicators.
Titan Biotech Ltd (524717) share price today is ₹757
Titan Biotech Ltd is not listed on NSE
Titan Biotech Ltd is listed on BSE
PE Ratio of Titan Biotech Ltd is 25.15
PE ratio = Titan Biotech Ltd Market price per share / Titan Biotech Ltd Earnings per share
Today’s traded volume of Titan Biotech Ltd(524717) is 7,876.00.
Today’s market capitalisation of Titan Biotech Ltd(524717) is ₹635.23Cr.
Titan Biotech Ltd(524717 | Price |
---|---|
52 Week High | ₹1017.85 |
52 Week Low | ₹375 |
Titan Biotech Ltd(524717) share price is ₹757. It is down -25.63% from its 52 Week High price of ₹1017.85
Titan Biotech Ltd(524717) share price is ₹757. It is up 101.87% from its 52 Week Low price of ₹375
Titan Biotech Ltd(524717 | Returns |
---|---|
1 Day Returns | -11.7% |
1 Month Returns | -21.69% |
3 Month Returns | 31.99% |
1 Year Returns | 89.2% |